The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2
Copyright policy )The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2
The optimisation of an HTS hit series (1) leading to the identification of structurally novel, selective, orally bioavailable mGluR2 positive modulators GSK1331258 and GSK1331268 is described. Structure-activity relationships, attenuation of dopaminergic activity, and potentiation of mGluR2 responses in rat hippocampal MPP-DG synapses are also reported.
- GlaxoSmithKline (United Kingdom) United Kingdom
- Cellzome, GSK, Middlesex, UK.
Dopamine, Administration, Oral, Synaptic Potentials, Receptors, Metabotropic Glutamate, Piperazines, High-Throughput Screening Assays, Rats, Structure-Activity Relationship, Allosteric Regulation, Animals, Benzimidazoles
Dopamine, Administration, Oral, Synaptic Potentials, Receptors, Metabotropic Glutamate, Piperazines, High-Throughput Screening Assays, Rats, Structure-Activity Relationship, Allosteric Regulation, Animals, Benzimidazoles
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).21 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!